MetLife Reports Strong Q1 Earnings, Exceeding Estimates with 23% EPS Growth and $1.1B Capital Return
MET sits 19% above its 52-week low of $67.33.
Summary
MetLife reported strong first-quarter 2026 results, with adjusted EPS up 23% to $2.42, surpassing estimates, and returned over $1.1 billion to shareholders through repurchases and dividends.
Key Events · Earnings and Guidance · MET
-
Strong Q1 Adjusted Earnings Beat
Adjusted earnings per share increased 23% to $2.42, surpassing analyst estimates, with total adjusted earnings rising 18% to $1.6 billion for the quarter ended March 31, 2026.
-
Significant Capital Return to Shareholders
MetLife returned over $1.1 billion to shareholders, including approximately $750 million in share repurchases and $370 million in common stock dividends during Q1 2026.
-
Robust Revenue and Segment Growth
Premiums, fees, and other revenues (PFOs) increased 5% to $14.3 billion, with adjusted PFOs (excluding pension risk transfers) up 10% to $13.3 billion across all operating segments. Asia's adjusted earnings grew 31% and MetLife Investment Management's grew 68%.
-
Improved Profitability and Efficiency
The adjusted Return on Equity (ROE) improved to 17.0%, and the direct expense ratio (excluding notable items and PRT) was 11.9%, ahead of the 12.1% annual target.
Analysis · MET · Finance
MetLife's Q1 2026 results demonstrate robust financial health and operational efficiency, with adjusted earnings per share significantly beating analyst expectations. The substantial capital return to shareholders, comprising $750 million in share repurchases and $370 million in dividends, signals strong confidence from management and a commitment to shareholder value. The widespread growth across all segments, particularly in Asia and MetLife Investment Management, coupled with an improved adjusted ROE and a direct expense ratio ahead of target, indicates a well-executed strategy. This comprehensive positive performance, following recent news of an EPS beat, solidifies a bullish outlook for the company.
At the time of this filing, MET was trading at $80.10 on NYSE in the Finance sector, with a market capitalization of approximately $52.3B. The 52-week trading range was $67.33 to $83.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.